These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
404 related items for PubMed ID: 17588560
1. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor. Cox ML, Haller VL, Welch SP. Eur J Pharmacol; 2007 Sep 10; 570(1-3):50-6. PubMed ID: 17588560 [Abstract] [Full Text] [Related]
2. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat. Craft RM, Wakley AA, Tsutsui KT, Laggart JD. J Pharmacol Exp Ther; 2012 Mar 10; 340(3):787-800. PubMed ID: 22182934 [Abstract] [Full Text] [Related]
3. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice. Haller VL, Cichewicz DL, Welch SP. Eur J Pharmacol; 2006 Sep 28; 546(1-3):60-8. PubMed ID: 16919265 [Abstract] [Full Text] [Related]
4. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat. Cox ML, Welch SP. Eur J Pharmacol; 2004 Jun 16; 493(1-3):65-74. PubMed ID: 15189765 [Abstract] [Full Text] [Related]
5. Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat. Scott DA, Wright CE, Angus JA. Pain; 2004 May 16; 109(1-2):124-31. PubMed ID: 15082134 [Abstract] [Full Text] [Related]
6. Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats. Smith FL, Fujimori K, Lowe J, Welch SP. Pharmacol Biochem Behav; 1998 May 16; 60(1):183-91. PubMed ID: 9610941 [Abstract] [Full Text] [Related]
7. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats. Calik MW, Carley DW. Sleep; 2017 Sep 01; 40(9):. PubMed ID: 28934522 [Abstract] [Full Text] [Related]
8. Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats. Järbe TU, Liu Q, Makriyannis A. Psychopharmacology (Berl); 2006 Jan 01; 184(1):36-45. PubMed ID: 16307294 [Abstract] [Full Text] [Related]
9. Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis. Gutierrez T, Farthing JN, Zvonok AM, Makriyannis A, Hohmann AG. Br J Pharmacol; 2007 Jan 01; 150(2):153-63. PubMed ID: 17160008 [Abstract] [Full Text] [Related]
10. Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain. Bagüés A, Martín MI, Sánchez-Robles EM. Eur J Pharmacol; 2014 Dec 15; 745():69-75. PubMed ID: 25446925 [Abstract] [Full Text] [Related]
11. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors. Smith PA, Selley DE, Sim-Selley LJ, Welch SP. Eur J Pharmacol; 2007 Oct 01; 571(2-3):129-37. PubMed ID: 17603035 [Abstract] [Full Text] [Related]
12. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain. Sagar DR, Jhaveri MD, Richardson D, Gray RA, de Lago E, Fernández-Ruiz J, Barrett DA, Kendall DA, Chapman V. Eur J Neurosci; 2010 Apr 01; 31(8):1414-22. PubMed ID: 20384778 [Abstract] [Full Text] [Related]
13. CB(1) receptor mediation of cannabinoid behavioral effects in male and female rats. Tseng AH, Craft RM. Psychopharmacology (Berl); 2004 Feb 01; 172(1):25-30. PubMed ID: 14991224 [Abstract] [Full Text] [Related]
14. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Nackley AG, Makriyannis A, Hohmann AG. Neuroscience; 2003 Feb 01; 119(3):747-57. PubMed ID: 12809695 [Abstract] [Full Text] [Related]
15. Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain. Curto-Reyes V, Llames S, Hidalgo A, Menéndez L, Baamonde A. Br J Pharmacol; 2010 Jun 01; 160(3):561-73. PubMed ID: 20233215 [Abstract] [Full Text] [Related]